World's Best Scientists 2026 revealed!
Mark H. Norman

Mark H. Norman

D-Index & Metrics

Chemistry

D-Index
48
Citations
8078
World Ranking
15259
National Ranking
416

Overview

Mark H. Norman is affiliated with Amgen (Canada) in Canada. Their research primarily focuses on Medicine, with a specialization in Cardiology and Cardiovascular Medicine. This specialization is reflected in their publications and the topics they explore within their work.

Norman's published works demonstrate a strong emphasis on atrial fibrillation management and outcomes, as well as cardiac arrhythmias and treatments. They also engage in studies related to health systems, economic evaluations, and quality of life, alongside literary interests in folklore, mythology, and literature studies.

Their research has been featured in the journal Heart Rhythm, where they have contributed multiple papers. Notable recent publications include:

  • CA-528-03 A REGISTRY REVIEW UPDATE OF 7120 CATHETER ABLATIONS FOR ATRIAL FIBRILLATION USING A DEDICATED ESOPHAGEAL TEMPERATURE CONTROL DEVICE FOR PROTECTION, 2022, Heart Rhythm
  • PO-711-03 A RANDOMISED COMPARISON OF METHODOLOGY IN CRYOBALLOON ABLATION FOR ATRIAL FIBRILLATION: RESULTS AT UP TO A DECADE, 2022, Heart Rhythm
  • PO-06-126 MULTI-CENTER ANALYSIS OF ONE-YEAR FREEDOM FROM ARRHYTHMIA FOLLOWING RADIOFREQUENCY ABLATION USING PROACTIVE ESOPHAGEAL COOLING, 2024, Heart Rhythm

These works collectively contribute to the understanding of treatment efficacy and procedural outcomes in atrial fibrillation, including catheter ablation techniques and esophageal temperature control protocols.

Norman has frequently collaborated with several researchers, including:

  • Zaki Akhtar
  • Abhay Bajpai
  • Zia Zuberi
  • Manav Sohal
  • Mark M. Gallagher

Their academic output also extends beyond journal articles. Norman has authored at least one book, The Folklore Of Devon, published by University of Exeter Press eBooks in 2022, reflecting interdisciplinary interests that include literature and cultural studies.

Best Publications

  • Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans.

    Narender R. Gavva;James J.S. Treanor;Andras Garami;Liang Fang

  • AMG 9810 [(E)-3-(4-t-Butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a Novel Vanilloid Receptor 1 (TRPV1) Antagonist with Antihyperalgesic Properties

    Narender R. Gavva;Rami Tamir;Yusheng Qu;Lana Klionsky

  • Vanilloid receptor ligands and their use in treatments

    Yunxin Y. Bo;Partha P. Chakrabarti;Ning Chen;Elizabeth M. Doherty

  • The Vanilloid Receptor TRPV1 Is Tonically Activated In Vivo and Involved in Body Temperature Regulation

    Narender R. Gavva;Anthony W. Bannon;Sekhar Surapaneni;David N. Hovland

  • The Transient Receptor Potential Vanilloid-1 Channel in Thermoregulation: A Thermosensor It Is Not

    Andrej A. Romanovsky;Maria C. Almeida;Andras Garami;Alexandre A. Steiner;Alexandre A. Steiner

  • Nonthermal Activation of Transient Receptor Potential Vanilloid-1 Channels in Abdominal Viscera Tonically Inhibits Autonomic Cold-Defense Effectors

    Alexandre A Steiner;Victoria F Turek;Maria C Almeida;Jeffrey J Burmeister

  • Effect of Linking Bridge Modifications on the Antipsychotic Profile of Some Phthalimide and Isoindolinone Derivatives

    Mark H. Norman;Douglas J. Minick;Greg C. Rigdon

  • Antihyperalgesic effects of (R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in rats.

    Sonya G. Lehto;Rami Tamir;Hong Deng;Lana Klionsky

  • Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade.

    Narender R. Gavva;Anthony W. Bannon;David N. Hovland;Sonya G. Lehto

  • [1,2,4]Triazolo[4,3-a]pyridinderivater der er nyttige som inhibitorer for hepatocytvækstfaktorreceptoren

    Bauer David;Bellon Steven;Booker Shon;Boezio Alessandro

  • Inhibitors of pi3 kinase

    Yunxin Y. Bo;Shon Booker;Marian Bryan;Holly L. Deak

  • Structure-activity relationships of a series of pyrrolo[3,2-d]pyrimidine derivatives and related compounds as neuropeptide Y5 receptor antagonists.

    Mark H. Norman;Ning Chen;Zhidong Chen;Christopher Fotsch

  • Nitrogen-containing heterocyclyl ketones and their use as c-met inhibitors

    Brian K. Albrecht;Steven Bellon;Shon Booker;Alan C. Cheng

  • Discovery of a Potent, Selective, and Orally Bioavailable c-Met Inhibitor: 1-(2-Hydroxy-2-methylpropyl)-N-(5-(7-methoxyquinolin-4-yloxy)pyridin-2-yl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxamide (AMG 458)

    Longbin Liu;Aaron Siegmund;Ning Xi;Paula Kaplan-Lefko

  • Discovery of Potent, Orally Available Vanilloid Receptor-1 Antagonists. Structure−Activity Relationship of N-Aryl Cinnamides

    Elizabeth M. Doherty;Christopher Fotsch;Yunxin Bo;Partha P. Chakrabarti

  • Discovery and Optimization of a Series of Benzothiazole Phosphoinositide 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Dual Inhibitors

    Noel D. D’Angelo;Tae-Seong Kim;Kristin Andrews;Shon K. Booker

  • Fused heterocyclic derivatives and methods of use

    Brian K. Albrecht;David Bauer;Steven Bellon;Christiane M. Bode

  • Acyclic stereoselection. 29. Stereoselection in the Michael addition reaction. 1. The Mukaiyama-Michael reaction

    Clayton H. Heathcock;Mark H. Norman;David E. Uehling

  • Design of Potent, Orally Available Antagonists of the Transient Receptor Potential Vanilloid 1. Structure−Activity Relationships of 2-Piperazin-1-yl-1H-benzimidazoles

    Vassil I. Ognyanov;Chenera Balan;Anthony W. Bannon;Yunxin Bo

  • Structure-based design of novel class II c-Met inhibitors: 1. Identification of pyrazolone-based derivatives.

    Mark H. Norman;Longbin Liu;Matthew Lee;Ning Xi

Frequent Co-Authors

Richard J. Lewis
Richard J. Lewis University of Queensland
Michael D. Bartberger
Michael D. Bartberger Amgen (United States)
Clayton H. Heathcock
Clayton H. Heathcock University of California, Berkeley
Christopher Hulme
Christopher Hulme University of Arizona

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Chemistry opens doors to diverse career paths, many of which can be explored through related online degrees and specialized training programs. For example, an important stepping stone in legal settings is a paralegal studies associate degree, which prepares students for roles that intersect with chemical patent law or compliance.

The pharmaceutical field offers promising opportunities for Chemistry graduates. Those interested in the business side might consider learning how to get into pharmaceutical sales, combining scientific knowledge with communication skills to support medication marketing and education.

For a more intensive clinical path, becoming a pharmacist is a highly respected goal. Though demanding, information on is it hard to become a pharmacist provides insights into the educational rigor and career rewards associated with this profession.

Alternatively, hands-on roles in forensic science and pathology, such as an autopsy technician, support the investigation of diseases and causes of death. Learning how to become an autopsy technician highlights the specialized education and job outlook for this niche.

Exploring these related fields enriches the practical applications of a Chemistry degree and enhances career versatility, especially through accessible online programs.

Best Scientists Citing Mark H. Norman

Trending Scientists